IL90462A - Controlled release dosage forms having a defined water content - Google Patents

Controlled release dosage forms having a defined water content

Info

Publication number
IL90462A
IL90462A IL90462A IL9046289A IL90462A IL 90462 A IL90462 A IL 90462A IL 90462 A IL90462 A IL 90462A IL 9046289 A IL9046289 A IL 9046289A IL 90462 A IL90462 A IL 90462A
Authority
IL
Israel
Prior art keywords
controlled release
water content
dosage forms
release dosage
defined water
Prior art date
Application number
IL90462A
Other languages
English (en)
Other versions
IL90462A0 (en
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL90462A0 publication Critical patent/IL90462A0/xx
Publication of IL90462A publication Critical patent/IL90462A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL90462A 1988-06-02 1989-05-30 Controlled release dosage forms having a defined water content IL90462A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (2)

Publication Number Publication Date
IL90462A0 IL90462A0 (en) 1990-01-18
IL90462A true IL90462A (en) 1993-01-31

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90462A IL90462A (en) 1988-06-02 1989-05-30 Controlled release dosage forms having a defined water content

Country Status (19)

Country Link
US (1) US5091189A (da)
EP (1) EP0344960B1 (da)
JP (1) JPH0816060B2 (da)
KR (1) KR0136279B1 (da)
AT (1) ATE83925T1 (da)
AU (1) AU610401B2 (da)
CA (1) CA1323834C (da)
DE (1) DE68904119T2 (da)
DK (1) DK175130B1 (da)
ES (1) ES2053989T3 (da)
FI (1) FI93695C (da)
GB (2) GB8813064D0 (da)
GR (1) GR3007088T3 (da)
IE (1) IE61998B1 (da)
IL (1) IL90462A (da)
NO (1) NO176232C (da)
NZ (1) NZ229372A (da)
PT (1) PT90722B (da)
ZA (1) ZA894201B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
ES2264226T3 (es) * 1997-12-22 2006-12-16 Euro-Celtique S.A. Forma farmaceutica de dosificacion oral que comprende una combinacion de un agonista opioide y naltrexona.
YU39500A (sh) * 1997-12-22 2003-02-28 Euro-Celtique S.A. Postupak sprečavanja zloupotrebe oblika za doziranje opijata
EP1133230A4 (en) 1998-11-23 2004-05-26 Bonnie M Davis DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS
PT1255547E (pt) 2000-02-08 2008-11-24 Euro Celtique Sa Composições de libertação controlada contendo agonistas e antagonistas opióides
WO2002092060A1 (en) 2001-05-11 2002-11-21 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
PT1416842E (pt) * 2001-07-18 2009-03-31 Euro Celtique Sa Composições farmacêuticas de oxicodona e naloxona
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
NZ530971A (en) 2001-08-06 2004-08-27 Euro Celtique S Oral dosage forms comprising an opioid agonist with releasable and sequestered opioid antagonists
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IN192180B (da) * 2001-09-28 2004-03-06 Ranbaxy Lab
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
US20050245556A1 (en) 2002-04-05 2005-11-03 Bianca Brogmann Pharmaceutical preparation containing oxycodone and naloxone
EP2422773A3 (en) * 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
DK1811957T3 (da) * 2004-10-19 2009-03-30 Krka Tovarna Zdravil D D Novo Fast farmaceutisk sammensætning omfattende donepezilhydrochlorid
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
UA91376C2 (ru) * 2005-08-24 2010-07-26 Рубикон Рисеч Пвт Лтд. Рецептура с контролируемым высвобождением
PT2719378T (pt) * 2006-06-19 2016-11-02 Alpharma Pharmaceuticals Llc Composições farmacêuticas
WO2008042279A2 (en) * 2006-09-29 2008-04-10 The Procter & Gamble Company Oral compositions containing gel networks
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
JP5406288B2 (ja) * 2008-07-07 2014-02-05 ユーロ−セルティーク エス．エイ． 尿閉を治療するためのオピオイド拮抗薬の使用
KR20140141727A (ko) 2009-03-10 2014-12-10 유로-셀티큐 에스.에이. 옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
JP2016525138A (ja) 2013-07-23 2016-08-22 ユーロ−セルティーク エス．エイ． 疼痛および腸内ディスバイオシスをもたらす疾患および／または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
AU3512789A (en) 1989-12-07
NO892229L (no) 1989-12-04
GB8911629D0 (en) 1989-07-05
JPH0816060B2 (ja) 1996-02-21
GR3007088T3 (da) 1993-07-30
PT90722A (pt) 1989-12-29
EP0344960A2 (en) 1989-12-06
DE68904119T2 (de) 1993-06-09
DK266889A (da) 1989-12-03
FI93695C (fi) 1995-05-26
ZA894201B (en) 1990-03-28
GB8813064D0 (en) 1988-07-06
NO176232C (no) 1995-03-01
FI892664A (fi) 1989-12-03
GB2219207A (en) 1989-12-06
IE61998B1 (en) 1994-12-14
DK175130B1 (da) 2004-06-14
NO892229D0 (no) 1989-06-01
FI892664A0 (fi) 1989-06-01
NO176232B (no) 1994-11-21
DE68904119D1 (de) 1993-02-11
EP0344960A3 (en) 1990-03-07
GB2219207B (en) 1992-01-02
EP0344960B1 (en) 1992-12-30
NZ229372A (en) 1991-07-26
IE891744L (en) 1989-12-02
AU610401B2 (en) 1991-05-16
ES2053989T3 (es) 1994-08-01
ATE83925T1 (de) 1993-01-15
IL90462A0 (en) 1990-01-18
PT90722B (pt) 1994-11-30
KR0136279B1 (ko) 1998-04-25
FI93695B (fi) 1995-02-15
JPH0225420A (ja) 1990-01-26
KR900000077A (ko) 1990-01-30
CA1323834C (en) 1993-11-02
DK266889D0 (da) 1989-06-01
US5091189A (en) 1992-02-25

Similar Documents

Publication Publication Date Title
GB2219207B (en) 3-alkylxanthine containing controlled release dosage forms having a defined water content
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
GB8825024D0 (en) Drug carrier
EP0295903A3 (en) Hair preparation
GR3004208T3 (da)
FR2640505B1 (fr) Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente
DE3379268D1 (en) 1'-(3-(1,2-benzisoxazol-3-yl)propyl)spiro-(benzofuran-2-(3h),3' or 4'-piperidine or 3'-pyrrolidines), a process for their preparation and their use as medicaments
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
ZA885372B (en) Nutrieut mixture intended for the elderly
GR3007347T3 (da)
EP0334097A3 (en) Process for the preparation of 4,4'-dihalogeno-bisphenyls
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
EP0269452A3 (en) Use of ketone derivatives for the manufacture of medicaments
HUT53610A (en) Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
PT88680A (pt) Dispositif de controle d'etancheite d'un recipient pour confinement d'un fluide sous pression
Kuczmann Behaviour of PVC Powder Grains Produced Using Suspension Technology, in Processing
Mahamwal Regulation of foreign investment in India
EP0337789A3 (en) Apparatus for oral administration of a medicament
Haines Hypnotherapeutic reductions of dental patient's distress
Carruthers More to Mitchell; the elusive art of WO Mitchell's Jake and the Kid.
FRANCIS THE MYTH OF" ZINC-FREE" BRONZES
AU2590688A (en) Child's chair with safety device
CS440287A1 (en) Device for level height's automatic regulation in crystallizer
AU7089687A (en) Child's small bed which can be transformed into an adult's bed

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed